These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3559209)

  • 1. Blood clearance of Streptococcus pneumoniae by C-reactive protein.
    Horowitz J; Volanakis JE; Briles DE
    J Immunol; 1987 Apr; 138(8):2598-603. PubMed ID: 3559209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.
    McDaniel LS; Benjamin WH; Forman C; Briles DE
    J Immunol; 1984 Dec; 133(6):3308-12. PubMed ID: 6491288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice.
    Yother J; Volanakis JE; Briles DE
    J Immunol; 1982 May; 128(5):2374-6. PubMed ID: 7061864
    [No Abstract]   [Full Text] [Related]  

  • 4. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice.
    Szalai AJ; Briles DE; Volanakis JE
    J Immunol; 1995 Sep; 155(5):2557-63. PubMed ID: 7650385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    Holzer TJ; Edwards KM; Gewurz H; Mold C
    J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae.
    Kerr AR; Wei XQ; Andrew PW; Mitchell TJ
    Microb Pathog; 2004 Jun; 36(6):303-10. PubMed ID: 15120156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.
    Briles DE; Hollingshead SK; King J; Swift A; Braun PA; Park MK; Ferguson LM; Nahm MH; Nabors GS
    J Infect Dis; 2000 Dec; 182(6):1694-701. PubMed ID: 11069242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors.
    Mold C; Rodic-Polic B; Du Clos TW
    J Immunol; 2002 Jun; 168(12):6375-81. PubMed ID: 12055255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms.
    Gang TB; Hanley GA; Agrawal A
    Infect Immun; 2015 May; 83(5):1845-52. PubMed ID: 25690104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice.
    Wu HY; Virolainen A; Mathews B; King J; Russell MW; Briles DE
    Microb Pathog; 1997 Sep; 23(3):127-37. PubMed ID: 9281471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae.
    Edwards KM; Gewurz H; Lint TF; Mold C
    J Immunol; 1982 Jun; 128(6):2493-6. PubMed ID: 7077077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
    Mohler J; Moine P; Azoulay-Dupuis E; Henin D; Fantin B
    Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of complement in the localization of pneumococci in the splanchnic reticuloendothelial system during experimental bacteremia.
    Brown EJ; Hosea SW; Frank MM
    J Immunol; 1981 Jun; 126(6):2230-5. PubMed ID: 7229372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB; Carter AT; Hitchin E; Wells JM
    J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC; Bosarge JR; Quin LR; McDaniel LS
    Vaccine; 2006 Jul; 24(29-30):5755-61. PubMed ID: 16759765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Invasive pneumococcal infections in patients with primary immunodeficiency disorders].
    Erdos M; Maródi L
    Orv Hetil; 2006 Apr; 147(17):799-804. PubMed ID: 16780188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-18 protects splenectomized mice from lethal Streptococcus pneumoniae sepsis independent of interferon-gamma by inducing IgM production.
    Kuranaga N; Kinoshita M; Kawabata T; Habu Y; Shinomiya N; Seki S
    J Infect Dis; 2006 Oct; 194(7):993-1002. PubMed ID: 16960788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.
    Szalai AJ; Briles DE; Volanakis JE
    Infect Immun; 1996 Nov; 64(11):4850-3. PubMed ID: 8890251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection.
    Nakayama S; Gewurz H; Holzer T; Du Clos TW; Mold C
    Clin Exp Immunol; 1983 Nov; 54(2):319-26. PubMed ID: 6652963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of polyamine transport in Streptococcus pneumoniae response to physiological stress and murine septicemia.
    Shah P; Romero DG; Swiatlo E
    Microb Pathog; 2008 Sep; 45(3):167-72. PubMed ID: 18572376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.